Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin for Prevention of Disseminated MAC in HIV
NCT00002336Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 1992
- Primary completion
- Nov 1994
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Mycobacterium avium complex infection (MAC) comparing Clarithromycin with Placebo (2 arms). Primary endpoint: Incidence of disseminated Mycobacterium avium complex infection. Started Nov 1992; status: completed.
02
Drugs
clarithromycin
03
Conditions
Mycobacterium avium complex infection (MAC)
Beyond the preview
Go deeper on NCT00002336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002336.